Amphastar Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMPH and other ETFs, options, and stocks.

About AMPH

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. 

CEO
Yong Feng Zhang
CEOYong Feng Zhang
Employees
2,028
Employees2,028
Headquarters
Rancho Cucamonga, California
HeadquartersRancho Cucamonga, California
Founded
1996
Founded1996
Employees
2,028
Employees2,028

AMPH Key Statistics

Market cap
1.20B
Market cap1.20B
Price-Earnings ratio
11.56
Price-Earnings ratio11.56
Dividend yield
Dividend yield
Average volume
375.87K
Average volume375.87K
High today
$26.23
High today$26.23
Low today
$25.42
Low today$25.42
Open price
$25.95
Open price$25.95
Volume
279.77K
Volume279.77K
52 Week high
$37.66
52 Week high$37.66
52 Week low
$20.39
52 Week low$20.39

Stock Snapshot

The current Amphastar Pharmaceuticals(AMPH) stock price is $26.07, with a market capitalization of 1.2B. The stock trades at a price-to-earnings (P/E) ratio of 11.56.

On 2026-01-19, Amphastar Pharmaceuticals(AMPH) stock moved within a range of $25.42 to $26.23. With shares now at $26.07, the stock is trading +2.6% above its intraday low and -0.6% below the session's peak.

Trading volume for Amphastar Pharmaceuticals(AMPH) stock has reached 279.77K, versus its average volume of 375.87K.

The stock's 52-week range extends from a low of $20.39 to a high of $37.66.

The stock's 52-week range extends from a low of $20.39 to a high of $37.66.

AMPH News

TipRanks 7d
Amphastar Licenses ACTH Analog AMP-110 for North America

Claim 70% Off TipRanks Premium An update from Amphastar Pharmaceuticals ( (AMPH) ) is now available. On January 12, 2026, Amphastar Pharmaceuticals announced...

Analyst ratings

57%

of 7 ratings
Buy
42.9%
Hold
57.1%
Sell
0%

People also own

Based on the portfolios of people who own AMPH. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the .